Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - agalsidase beta, quantity: 35 mg - injection, powder for - excipient ingredients: monobasic sodium phosphate; nitrogen; dibasic sodium phosphate heptahydrate; mannitol - fabrazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (alpha-galactosidase deficiency).

Singapore - English - HSA (Health Sciences Authority)

celltrion healthcare singapore private limited - distigmine bromide - tablet - 5 mg - distigmine bromide 5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

sandoz gmbh, kundl - clorhidrato de naftifina - clorhidrato de naftifina....0.01 g

United States - English - NLM (National Library of Medicine)

meditrend, inc. dba progena professional formulations - echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), myrrh (unii: jc71gj1f3l) (myrrh - unii:jc71gj1f3l), nasturtium officinale (unii: yh89gmv676) (nasturtium officinale - unii:yh89gmv676), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), fenugreek leaf (unii: 487ri96k8z) (fenugr - echinacea, unspecified 3 [hp_x] in 1 ml - purpose: relief from sneezing, runny nose, itchy eyes and sinus congestion. use: this product is a homeopathic dilution formulated to support the body's immunity for the temporary relief of allergies.

United States - English - NLM (National Library of Medicine)

greer laboratories, inc. - sporisorium cruentum (unii: gqm6lvu5v8) (sporisorium cruentum - unii:gqm6lvu5v8) - allergenic extracts are indicated for the diagnosis and treatment of patients with immediate hypersensitivity allergy to the respective allergens, inhaled, ingested or otherwise introduced into contact with sensitive tissues. the diagnosis of ige‑mediated allergy may be established by the allergy history, clinical evaluation, and skin test reactivity. (4,7,11) immunotherapy with allergenic extracts is indicated when testing and patient history have identified the offending allergens and when it is not possible or practical to avoid these allergens. (12‑14) food extracts have not been proven effective in immunotherapy. the use of allergenic extracts for the above purposes should be made only by physicians with special familiarity and knowledge of allergy. (see dosage and administration) there are no known absolute contraindications to the use of allergenic extracts for immunotherapy. immunotherapy with specific antigens should not be done in those individuals who do not exhibit skin test or clinical sens

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 10000 [pnu] in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - solidago canadensis pollen (unii: 644cz16ir5) (solidago canadensis pollen - unii:644cz16ir5) - equus caballus skin 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse

United States - English - NLM (National Library of Medicine)

allergy laboratories, inc. - apple (unii: b423vgh5s9) (apple - unii:b423vgh5s9) - apple 1 g in 20 ml - immunotherapy using allergenic extracts is indicated for use in patients with severe allergy symptoms (hay fever, rhinitis, etc.) to pollens, molds, insects, animal danders and various other allergens. immunotherapy is intended for patients whose symptoms are not satisfactorily controlled by avoidance of the offending allergen or by the use of symptomatic medications. treatment uses only those specific allergens that the patient is sensitive to based on diagnostic tests and medical history. it is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no known absolute contraindications to diagnostic testing or hyposensitization with allergen immunotherapy.  patients with cardiovascular disease or pulmonary disease such as symptomatic asthma, and/or who are receiving cardiovascular drugs such as beta blockers, may be at higher risk for severe adverse reactions. these patients may also be more refractory to the

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - rectum 12x - for the temporary relief of constipation or a change in bowel habits, bloating, flatulence, or mild abdominal discomfort.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - all the following at 30x, 60x: alternaria aspergillus mix (aspergillus flavus, fumigatus, glaucus, niger, and nidulans) chaetomium sp. cladosporium cryptococcus neoformans helminthosporium histoplasma capsulatum penicillium notatum stachybotrys chartarum - for the temporary relief of nasal irritation or congestion, cough, shortness of breath, occasional headaches, irritability, or fatigue.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.